British journal of haematology, 2020-02, Vol.188 (3), p.e24-e27
- Van de Wyngaert, Zoe
- Carpentier, Benjamin
- Pascal, Laurent
- Lionne‐Huyghe, Pauline
- Leduc, Isabelle
- Srour, Micha
- Vasseur, Michele
- Demarquette, Helene
- Terriou, Louis
- Herbaux, Charles
- Manier, Salomon
- Bossard, Jean‐Baptiste
- Barbieux, Sarah
- Chauvet, Paul
- Willaume, Alexandre
- Nudel, Morgane
- Bories, Claire
- Gibier, Jean‐Baptiste
- Facon, Thierry
- Boyle, Eileen M.
2020
Details
- Autor(en) / Beteiligte
- Van de Wyngaert, Zoe
- Carpentier, Benjamin
- Pascal, Laurent
- Lionne‐Huyghe, Pauline
- Leduc, Isabelle
- Srour, Micha
- Vasseur, Michele
- Demarquette, Helene
- Terriou, Louis
- Herbaux, Charles
- Manier, Salomon
- Bossard, Jean‐Baptiste
- Barbieux, Sarah
- Chauvet, Paul
- Willaume, Alexandre
- Nudel, Morgane
- Bories, Claire
- Gibier, Jean‐Baptiste
- Facon, Thierry
- Boyle, Eileen M.
- Titel
- Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
- Ist Teil von
- British journal of haematology, 2020-02, Vol.188 (3), p.e24-e27
- Ort / Verlag
- England: Blackwell Publishing Ltd
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- Wiley Online Library All Journals
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0007-1048eISSN: 1365-2141DOI: 10.1111/bjh.16282Titel-ID: cdi_hal_primary_oai_HAL_hal_04219636v1
- Format
- –
- Schlagworte
- AL‐Amyloidosis, Amyloidosis, daratumumab, frailty, Hematology, Life Sciences